| Variable | N | Percent (%) |
| Age (ys) | 53.4 ± 11.7 | |
| <60 | 441 | 79.3 |
| ≥60 | 115 | 20.7 |
| Sex |
|
|
| Male | 448 | 80.6 |
| Female | 108 | 19.4 |
| Hepatitis etiology |
|
|
| HBV | 513 | 92.3 |
| HCV | 2 | 0.3 |
| No | 41 | 7.4 |
| Serum AFP level (ng/ml) | 130.6 (0.7 - 339,567) | |
| <20 ng/ml | 189 | 34.0 |
| ≥20 ng/ml | 367 | 66.0 |
| Liver function |
|
|
| Child-pugh A | 473 | 85.1 |
| Child-pugh B | 68 | 12.2 |
| Child-pugh C | 15 | 2.7 |
| Site of recurrence |
|
|
| Intrahepatic | 516 | 92.8 |
| Extrahepatic | 17 | 3.1 |
| Intrahepatic and extrahepatic | 23 | 4.1 |
| Tumor size (cm) | 6.1 ± 10.5 | |
| Tumor nodule |
|
|
| Single | 298 | 51.7 |
| Multiple | 258 | 44.8 |
| Tumor thrombus |
|
|
| Yes | 40 | 6.9 |
| No | 516 | 89.6 |
| Clinical stages |
|
|
| Early stage | 298 | 53.6 |
| Intermediate stage | 214 | 38.5 |
| Advanced stage | 32 | 5.7 |
| Terminal stage | 12 | 2.2 |
| Disease-free interval (months) | 8 (2 - 195) | |